Related Experiment Videos
CDK4 down-regulation induced by paclitaxel is associated with G1 arrest in gastric cancer cells
1Laboratory of Experimental Therapeutics, Korea Cancer Center Hospital, Seoul.
Abstract:
Paclitaxel induces a cell cycle block at G2-M phase by preventing the depolymerization of microtubules and induces p53-independent apoptosis in many cancer cells. We observed that gastric cancer cells treated with paclitaxel have shown a cyclin-dependent kinase (CDK)4 down-regulation. This paclitaxel-induced CDK4 down-regulation resulted in a cell cycle arrest at G1-S phase. To confirm this observation, we prepared stable transfectants that overexpressed CDK4 and analyzed the cell cycle progression. Ectopic expression of CDK4 in SNU cells resulted in a release of paclitaxel-induced G1 arrest. The release of G1 arrest by enforced expression of CDK4 seems to make the cells more sensitive to paclitaxel-induced apoptosis. From this finding, we could then suggest that paclitaxel treatment induces both G1-S and G2-M blocks in the cell cycle progression of gastric cancer cells.
Insights
Paclitaxel causes gastric cancer cells to arrest at two cell cycle phases, G1-S and G2-M. Overexpressing CDK4 releases the G1-S arrest, increasing sensitivity to paclitaxel-induced apoptosis.
Area of Science:
- Oncology
- Cell Biology
- Molecular Pharmacology
Background:
- Paclitaxel is a chemotherapy agent known to induce G2-M cell cycle arrest by stabilizing microtubules.
- Gastric cancer cells exhibit p53-independent apoptosis following paclitaxel treatment.
- A novel observation in gastric cancer cells is the down-regulation of cyclin-dependent kinase (CDK)4 upon paclitaxel exposure.
Purpose of the Study:
- To investigate the role of paclitaxel-induced CDK4 down-regulation in gastric cancer cell cycle progression.
- To determine the impact of CDK4 expression levels on paclitaxel sensitivity and apoptosis.
Main Methods:
- Gastric cancer cell lines (SNU cells) were treated with paclitaxel.
- Cyclin-dependent kinase (CDK)4 expression levels were analyzed.
- Stable transfectants overexpressing CDK4 were generated.
- Cell cycle progression was analyzed using flow cytometry.
Main Results:
- Paclitaxel treatment led to down-regulation of CDK4 in gastric cancer cells.
- This CDK4 down-regulation resulted in cell cycle arrest at the G1-S phase.
- Ectopic expression of CDK4 in SNU cells released the paclitaxel-induced G1-S phase arrest.
- Enforced CDK4 expression sensitized cells to paclitaxel-induced apoptosis.
Conclusions:
- Paclitaxel induces a dual cell cycle block in gastric cancer cells, affecting both G1-S and G2-M phases.
- CDK4 plays a critical role in mediating the G1-S phase arrest induced by paclitaxel.
- Modulating CDK4 expression could be a potential strategy to enhance paclitaxel efficacy in gastric cancer treatment.